SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
212.50    0.00 (0.00%)
Bid:
210.00
Ask:
215.00
Spread: 5.00 (2.381%)
Market Cap: £145.08m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Scrip Dividend Reference Price

12 Jun 2026 07:00

RNS Number : 0127I
Helios Underwriting Plc
12 June 2026
 

12 June 2026

 

Helios Underwriting plc

('Helios' or 'the Company')

 

Scrip Dividend Reference Price

 

Helios, the only publicly traded company offering instant access to a diverse portfolio of syndicates at Lloyd's of London, the world's largest insurance market, announces that the scrip dividend reference price for the fully paid ordinary shares to be issued to shareholders electing to receive the scrip dividend alternative for the total dividend of 7.0p per share and the special dividend of 3.0p per share for the year ended 31 December 2025 will be 214.1p per share.

 

The scrip reference price is calculated as the average of the Company's closing middle market share price for the five consecutive dealing days commencing on the ex-dividend date of 4 June 2026.

 

The timetable for the proposed scrip dividend, which remains subject to approval at the Company's Annual General Meeting to be held on 22 June 2026, is as follows:

 

26 June 2026

Final date for receipt of Scrip Dividend Mandate Election forms and CREST Dividend Election Input Messages

10 July 2026

Allotment of New Shares to Certificated and CREST Shareholders and admission for trading

 

 

For further information, please contact:

Helios Underwriting plc

Louis Tucker - Chief Executive Officer +44 (0)20 3965 6441 

Adhiraj Maitra - Director of Finance and Operations +44 (0)20 3743 2114

 

Peel Hunt (Nomad, Broker and Financial Adviser)

Dan Webster / Andrew Buchanan / Martin Frowde +44 (0) 20 7418 8900

 

Singer Capital Markets (Joint Broker)

Charles Leigh-Pemberton / Russell Cook / James Todd   +44 (0)20 7496 3000

 

FTI Consulting

Ed Berry +44 (0)7703 330 199

Christian Harte +44 (0)7974 288 763

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market. The portfolio provides a broad spread of business primarily participating in the US and other international wholesale and reinsurance markets. For further information please visit www.huwplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEAKKFFEPKEFA
Date   Source Headline
9th Jun 20251:15 pmRNSGrant of LTIP Awards
2nd Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20257:00 amRNSFinal results for the year ended 31 December 2024
29th May 20257:06 amRNSDirectorate Change
29th May 20257:03 amRNSCompany Announcement
29th May 20257:00 amRNSHelios Underwriting 2024 Preliminary Results
20th May 20257:00 amRNSNotice of Results and Change in Accounting
10th Apr 20253:41 pmRNSDirector Shareholding
9th Apr 202512:22 pmRNSDirector/PDMR Shareholding
8th Apr 20257:02 amRNSShare Repurchase Programme - 2025
8th Apr 20257:00 amRNSNet Asset Value as at 31 December 2024
13th Mar 20257:00 amRNSDirector/PDMR Shareholding
10th Feb 20257:00 amRNSDirectorate Change
18th Dec 20247:00 amRNS2025 Capacity Update
15th Nov 20247:00 amRNSCapacity Value Update
3rd Oct 20242:08 pmRNSInvestor Presentation via Investor Meet Company
30th Sep 20247:00 amRNSGrant of LTIP Awards
27th Sep 20247:00 amRNSHalf Year Results
23rd Sep 20247:00 amRNSTR-1: Notification of major holdings
30th Aug 20247:00 amRNSAppointment of Non-Executive Director
1st Aug 20247:00 amRNSTotal Voting Rights
31st Jul 20247:00 amRNSNet Asset Value as at 31 March 2024
24th Jul 20245:36 pmRNSHolding(s) in Company
23rd Jul 20245:05 pmRNSCompletion of Share Buy-Back
17th Jul 20248:50 amRNSDirector/PDMR Shareholding
12th Jul 20247:00 amRNSIssue of Equity
10th Jul 20247:00 amRNSResults of Scrip Dividend Election
9th Jul 20247:00 amRNSShare Repurchase Programme - 2024
1st Jul 20247:00 amRNSDirectorate Change
28th Jun 202411:25 amRNSResults of Annual General Meeting
28th Jun 20247:00 amRNSAGM Statement
19th Jun 20247:00 amRNSShare Repurchase Programme
17th Jun 20247:00 amRNSGrant of LTIP Awards
14th Jun 20247:00 amRNSScrip Dividend Reference Price
7th Jun 20247:00 amRNSDirectorate Change
4th Jun 20247:00 amRNSPosting of Annual Report and Notice of AGM
3rd Jun 20243:19 pmRNSDirector's Shareholding
30th May 20247:00 amRNSFinal results for the year ended 31 December 2023
22nd Apr 20247:00 amRNSDirectorate Change
25th Mar 20242:53 pmRNSChange of Registered Office
22nd Mar 20247:00 amRNSNAV Update - 31 December 2023
4th Mar 20247:00 amRNSHelios appoints Adhiraj Maitra as COO
1st Feb 20247:00 amRNSTotal Voting Rights
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.